Ibrexafungerp

Cat. No. M10833

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

SCY-078; MK-3118

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Ibrexafungerp is a novel, orally available glucan synthase inhibitor with in vitro activity against many echinocandin-resistant Candida strains.

Molecular Weight	730.03
Formula	C44H67N5O4
CAS Number	1207753-03-4
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Anti-infection Products
PSI-6206 PSI-6206 is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM.
BTZ043 Racemate BTZ043 Racemate (BTZ038, BTZ044) is a decaprenylphosphoryl-b-D-ribose 2-epimerase inhibitor.
Enoxacin Enoxacin is a small molecule inhibitor of binding between the B2-subunit of vacuolar H+-ATPase (V-ATPase) and microfilaments.
Posaconazole Posaconazole is a sterol C14α demethylase inhibitor with IC50 of 0.25 nM.
Pretomanid Pretomanid (PA-824) is a novel, orally active nitroimidazole derivative with antimycobacterial activity for use in tuberculosis-related studies.

Catalog